IFOSFAMIDE BY CONTINUOUS INFUSION TO PREVENT ENCEPHALOPATHY

被引：74

作者：

CERNY, T

CASTIGLIONE, M

BRUNNER, K

KUPFER, A

MARTINELLI, G

LIND, M

机构：

[1] UNIV BERN,INST CLIN PHARMACOL,CH-3000 BERN,SWITZERLAND

[2] OSPED SAN GIOVANNI BELLINZONA,ONCOL SERV,BELLINZONA,SWITZERLAND

[3] NEWCASTLE GEN HOSP,DEPT CLIN ONCOL,NEWCASTLE TYNE NE4 6BE,TYNE & WEAR,ENGLAND

来源：

LANCET | 1990年 / 335卷 / 8682期

关键词：

D O I：

10.1016/0140-6736(90)90053-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：175 / 175

页数：1

共 11 条

[1] RESPONSE TO IFOSFAMIDE AND MESNA - 124 PREVIOUSLY TREATED PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA [J].

ANTMAN, KH ;

RYAN, L ;

ELIAS, A ;

SHERMAN, D ;

GRIER, HE .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) :126-131

[2] A SIMPLE OUTPATIENT TREATMENT WITH ORAL IFOSFAMIDE AND ORAL ETOPOSIDE FOR PATIENTS WITH SMALL CELL LUNG-CANCER (SCLC) [J].

CERNY, T ;

LIND, M ;

THATCHER, N ;

SWINDELL, R ;

STOUT, R .

BRITISH JOURNAL OF CANCER, 1989, 60 (02) :258-261

[3]

CERNY T, 1987, CANCER CHEMOTH PHARM, V18, P261

[4]

CERNY T, 1989, P ECCO LONDON, V5

[5] RESPONSE TO MESNA, DOXORUBICIN, IFOSFAMIDE, AND DACARBAZINE IN 108 PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA AND NO PRIOR CHEMOTHERAPY [J].

ELIAS, A ;

RYAN, L ;

SULKES, A ;

COLLINS, J ;

AISNER, J ;

ANTMAN, KH .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (09) :1208-1216

[6]

ELIAS A, 1989, ASCO P, V8, P264

[7]

GOREN MP, 1986, LANCET, V2, P1219

[8]

LIND MJ, 1989, CANCER RES, V49, P753

[9]

Pratt CB, 1989, CANCER CHEMOTHER P S, V24, pS24

[10]

WATKIN SW, 1989, EUR J CANCER CLIN ON, P1303

← 1 2 →